Detalhe da pesquisa
1.
Implicating the cholecystokinin B receptor in liver stem cell oncogenesis.
Am J Physiol Gastrointest Liver Physiol
; 326(3): G291-G309, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38252699
2.
A 584 bp deletion in CTRB2 inhibits chymotrypsin B2 activity and secretion and confers risk of pancreatic cancer.
Am J Hum Genet
; 108(10): 1852-1865, 2021 10 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34559995
3.
Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma.
Int J Mol Sci
; 24(4)2023 Feb 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36835036
4.
Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression.
Int J Mol Sci
; 24(1)2023 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36614194
5.
Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome.
Int J Mol Sci
; 23(3)2022 Feb 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35163821
6.
Cholecystokinin Receptor Antagonist Therapy Decreases Inflammation and Fibrosis in Chronic Pancreatitis.
Dig Dis Sci
; 65(5): 1376-1384, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31598921
7.
A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
Dig Dis Sci
; 65(1): 189-203, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31297627
8.
Vaccine against gastrin, a polyclonal antibody stimulator, decreases pancreatic cancer metastases.
Am J Physiol Gastrointest Liver Physiol
; 317(5): G682-G693, 2019 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31433212
9.
ISG15 pathway knockdown reverses pancreatic cancer cell transformation and decreases murine pancreatic tumor growth via downregulation of PDL-1 expression.
Cancer Immunol Immunother
; 68(12): 2029-2039, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31709456
10.
Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment.
Cancer Immunol Immunother
; 68(10): 1635-1648, 2019 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-31549214
11.
Characterising cis-regulatory variation in the transcriptome of histologically normal and tumour-derived pancreatic tissues.
Gut
; 67(3): 521-533, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28634199
12.
Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor.
Am J Physiol Gastrointest Liver Physiol
; 315(5): G699-G712, 2018 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29927319
13.
Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice.
Cancer Immunol Immunother
; 67(2): 195-207, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29043413
14.
Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer.
Nanomedicine
; 13(7): 2313-2324, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28673852
15.
Cholecystokinin and pancreatic cancer: the chicken or the egg?
Am J Physiol Gastrointest Liver Physiol
; 306(2): G91-G101, 2014 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-24177032
16.
Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat.
Dig Dis Sci
; 59(6): 1180-91, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24817409
17.
The Role of a Cholecystokinin Receptor Antagonist in the Management of Chronic Pancreatitis: A Phase 1 Trial.
Pharmaceutics
; 16(5)2024 Apr 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38794273
18.
Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn's disease: a pilot study.
J Clin Gastroenterol
; 47(4): 339-45, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23188075
19.
Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic.
Cancers (Basel)
; 15(10)2023 May 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37345148
20.
Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis.
Am J Physiol Gastrointest Liver Physiol
; 302(11): G1244-52, 2012 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22442157